Senestech Price to Book Ratio 2015-2025 | SNES
Historical price to book ratio values for Senestech (SNES) over the last 10 years. The current price to book ratio for Senestech as of July 09, 2025 is 3.10.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Senestech Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-10 | 5.12 | 3.14 | |
| 2025-03-31 | 1.81 | $1.63 | 1.11 |
| 2024-12-31 | 3.31 | $2.42 | 1.37 |
| 2024-09-30 | 2.58 | $3.60 | 0.72 |
| 2024-06-30 | 5.76 | $6.04 | 0.95 |
| 2024-03-31 | 6.83 | $8.96 | 0.76 |
| 2023-12-31 | 12.70 | $12.36 | 1.03 |
| 2023-09-30 | 50.40 | $100.90 | 0.50 |
| 2023-06-30 | 134.40 | $114.50 | 1.17 |
| 2023-03-31 | 178.80 | $199.24 | 0.90 |
| 2022-12-31 | 370.80 | $787.91 | 0.47 |
| 2022-09-30 | 841.20 | $600.98 | 1.40 |
| 2022-06-30 | 1265.76 | $1,093.83 | 1.16 |
| 2022-03-31 | 1752.00 | $1,558.50 | 1.12 |
| 2021-12-31 | 2349.12 | $1,974.89 | 1.19 |
| 2021-09-30 | 3624.00 | $2,420.85 | 1.50 |
| 2021-06-30 | 3864.00 | $2,822.43 | 1.37 |
| 2021-03-31 | 3984.00 | $3,128.12 | 1.27 |
| 2020-12-31 | 4140.00 | $1,828.50 | 2.26 |
| 2020-09-30 | 4512.00 | $0.92 | 4888.41 |
| 2020-06-30 | 4800.00 | $1.44 | 3331.02 |
| 2020-03-31 | 4968.00 | $1.14 | 4355.22 |
| 2019-12-31 | 26400.00 | $1.82 | 14537.44 |
| 2019-09-30 | 48480.00 | $0.18 | 266081.23 |
| 2019-06-30 | 86400.00 | $0.16 | 554913.29 |
| 2019-03-31 | 58560.00 | $0.18 | 322822.49 |
| 2018-12-31 | 28089.60 | $5.38 | 5217.62 |
| 2018-09-30 | 33120.00 | $0.37 | 89731.78 |
| 2018-06-30 | 78240.00 | $0.31 | 248934.14 |
| 2018-03-31 | 24480.00 | $0.34 | 72684.09 |
| 2017-12-31 | 34560.00 | $0.46 | 75294.12 |
| 2017-09-30 | 88800.00 | $0.35 | 250493.65 |
| 2017-06-30 | 273600.00 | $0.55 | 498269.90 |
| 2017-03-31 | 379680.00 | $0.83 | 457005.30 |
| 2016-12-31 | 391200.00 | $1.07 | 366635.43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.011B | $0.002B |
| SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company's fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |